Skip to main content
SpringerLink
Log in

PGx test for statin-induced myopathy cost effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 Canadian dollars

Reference

  • Mitchell D, et al. Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin. Molecular Diagnosis and Therapy : 31 Oct 2016. Available from: URL: http://doi.org/10.1007/s40291-016-0238-8

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

PGx test for statin-induced myopathy cost effective. PharmacoEcon Outcomes News 766, 24 (2016). https://doi.org/10.1007/s40274-016-3545-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-3545-8

Search

Navigation